213 related articles for article (PubMed ID: 37420331)
1. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
2. Ultrathin Clay Nanoparticles-Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy.
Liu J; Zhan J; Zhang Y; Huang L; Yang J; Feng J; Ding L; Shen Z; Chen X
Adv Mater; 2024 Mar; 36(9):e2309562. PubMed ID: 37939375
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
[TBL] [Abstract][Full Text] [Related]
4. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
5. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
6. Transformable Supramolecular Self-Assembled Peptides for Cascade Self-Enhanced Ferroptosis Primed Cancer Immunotherapy.
Wang H; Jiao D; Feng D; Liu Q; Huang Y; Hou J; Ding D; Zhang W
Adv Mater; 2024 May; 36(21):e2311733. PubMed ID: 38339920
[TBL] [Abstract][Full Text] [Related]
7. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
8. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
[TBL] [Abstract][Full Text] [Related]
9. Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy.
Zhou Y; Chen K; Lin WK; Liu J; Kang W; Zhang Y; Yang R; Jin L; Cheng Y; Xu A; Wang W
Adv Healthc Mater; 2023 Oct; 12(27):e2300994. PubMed ID: 37432874
[TBL] [Abstract][Full Text] [Related]
10. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy.
Wang J; Wang Z; Li L; Wang M; Chang J; Gao M; Wang D; Li C
Acta Biomater; 2024 Jun; 181():362-374. PubMed ID: 38663684
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy.
Chen M; Shen Y; Pu Y; Zhou B; Bing J; Ge M; Zhu Y; Gao S; Wu W; Zhou M; Shi J
Biomaterials; 2023 Dec; 303():122386. PubMed ID: 37977008
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.
Zhao Z; Dong S; Liu Y; Wang J; Ba L; Zhang C; Cao X; Wu C; Yang P
ACS Nano; 2022 Dec; 16(12):20400-20418. PubMed ID: 36441901
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Based MRI-Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF-β Signaling.
Zhou R; Liu Y; Wang Z; Lv J; Liao W; Shen Z; Rong X
Adv Healthc Mater; 2023 Aug; 12(21):e2300176. PubMed ID: 37093559
[TBL] [Abstract][Full Text] [Related]
14. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
15. Heterostructural Nanoadjuvant CuSe/CoSe
Yang C; Wang M; Chang M; Yuan M; Zhang W; Tan J; Ding B; Ma P; Lin J
J Am Chem Soc; 2023 Apr; 145(13):7205-7217. PubMed ID: 36958054
[TBL] [Abstract][Full Text] [Related]
16. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment.
Cheng Z; Xue C; Liu M; Cheng Z; Tian G; Li M; Xue R; Yao X; Zhang Y; Luo Z
Acta Biomater; 2023 Oct; 169():289-305. PubMed ID: 37544392
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis.
Zhao RR; Wu JH; Tong LW; Li JY; Lu YS; Shao JW
J Colloid Interface Sci; 2024 Apr; 660():257-276. PubMed ID: 38244494
[TBL] [Abstract][Full Text] [Related]
18. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
19. Engineered Microbial Nanohybrids for Tumor-Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and Immunotherapy.
Ruan Y; Zhuang H; Zeng X; Lin L; Wang X; Xue P; Xu S; Chen Q; Yan S; Huang W
Adv Healthc Mater; 2024 Feb; 13(4):e2302537. PubMed ID: 37742322
[TBL] [Abstract][Full Text] [Related]
20. A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy.
Yang Q; Liu T; Zheng H; Zhou Z; Huang Y; Jia H; Fu S; Zhang X; Zhang H; Liu Y; Chen X; Shan W
Biomaterials; 2023 Jan; 292():121936. PubMed ID: 36502663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]